US 8828971
Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
granted A61KA61K31/7105A61K31/715
Quick answer
US patent 8828971 (Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders) held by GALECTIN THERAPEUTICS, INC. expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- GALECTIN THERAPEUTICS, INC.
- Grant date
- Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/7105, A61K31/715, A61K38/02, A61K45/06